| CARD ID | 141 | |
| Type of strain | Targeted mutant. | |
| Strain name | B6.129P2-Itgb2tm1Oci | |
| Internal Code | B6.129p2-Lfa1tm1 N6 | |
| Submitter | Shigeo Koyasu | |
| Submitter affiliation or code | RIKEN | |
| Stock Type | ||
| Material Transfer Conditions |
Consent to us
|
|
| Production method | From other organizations | |
| Origin (In-house) | Organization | |
| Organization code | ||
| Developer | ||
| Origin (From other organizations) | Organization | Ontario Cancer Institute |
| Organization code | Oci | |
| Developer | Tak W. Mak | |
| Year introduced | 1998 | |
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | Itgb2(Lfa1) |
| Gene name | Integrin beta 2 |
| Allele symbol | |
| Allele name | |
| MGI | MGI:96611, |
| Chromosome | 10 (41.5cM) , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | |
| GO | Gene Ontology |
| OMIM | OMIM ID: 600065 Human Gene Symbol: ITGB2, |
| Author | Rudolf Schmits, Thomas M.Kundig, Dianne M.Baker, Grace Shumaker, Jhon J.L.Simard, Gordon Duncan, Andrew Wakeham, Arda Shahinian, Annette van der Heiden, Martin F.Bachmann, Pamela S.Ohashi, Tak W.Mak, and Dennis D.Hickstein |
| Title | LFA-1-deficient Mice Show Normal CTL Responses to Virus but Fail to Reject Immunogenic Tumor |
| Journal | The Journal of Experimental Medicine |
| Volume | 183 |
| Page | 1415-1426 |
| Year | 1996 |
| PMID | 8666900 |
| Disease name, Applicable field |